Pfizer Ventures Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 9
- Investments
- 149
- Portfolio
- 51
- Exits
- 68
Pfizer Ventures General Information
Description
Founded in 2004, Pfizer Ventures is a venture capital firm based in New York, New York. The firm is a corporate venture capital arm of Pfizer Inc that seeks to invest in companies based in the United States operating in the healthcare sector.
Contact Information
Website
Year Founded
2004
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 235 East 42nd Street
- New York, NY 10017
- United States
+1 (212) 000-0000
Pfizer Ventures Investments (149)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Palleon Pharmaceuticals | 16-Sep-2020 | Later Stage VC | 00000 | Drug Discovery | Pre-Clinical Trials | 0000000 0000000 |
| 0000000 0000000000 | 15-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 0000000 00000 00.0 |
| 0000000 0000000000 | 06-Jul-2020 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 0000000 00.0 |
| 0000 0000000000000 | 01-Jul-2020 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| 000000 00000000000 | 25-Jun-2020 | 00000 00000 | 0000 | Pharmaceuticals | Startup | |
| 00000000 000000000 | 24-Jun-2020 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| 0000 | 16-Jun-2020 | 00000 00000 | 0000 | Biotechnology | Generating Revenue/Not Profitable | 0000000 0000000 |
| 0000000 | 10-Jun-2020 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| Autobahn Therapeutics | 09-Jun-2020 | Early Stage VC | 000.00 | Biotechnology | Product In Beta Test | |
| FoRx Therapeutics | 22-Apr-2020 | Seed Round | 000.00 | Drug Discovery | Startup | 00000 0000000 00.0 |
Pfizer Ventures Exits (68)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| NeuMoDx Molecular | 17-Sep-2020 | Merger/Acquisition | 00000 |
| 000000 00000000000 | 21-Aug-2020 | 000 | 00000 |
| 00000 | 12-Mar-2020 | 000 | 000.00 |
| 00000000000 000000 | 13-Sep-2019 | 000 | 00000 |
| 000000000 | 01-Jul-2019 | 000000000000000000 | 00000 |
| 0000000 0000000000 | 27-Jun-2019 | 000 | 0000 |
| 000000000 | 09-May-2019 | 000 | 0000 |
| 00000000 | 09-May-2019 | 000 | 0000 |
| Neuronetics | 28-Jun-2018 | IPO | 000.00 |
| Translate Bio | 28-Jun-2018 | IPO | 00000 |
Pfizer Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialPfizer Ventures Team (11)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Denis Patrick Ph.D | Managing Partner & Vice President, WRDM | 0 | 0 | New York, NY | |
| Barbara Dalton Ph.D | Vice President, WWBD & Senior Managing Partner | 00 | 0 | 0 | New York, NY |
| William Burkoth | Senior Partner & Executive Director, WWBD | 00 | 00 | New York, NY | |
| Christopher O'Donnell Ph.D | Partner & Executive Director, WRDM | 0 | 0 | New York, NY | |
| Michael Baran Ph.D | Partner & Executive Director, WRDM | 0 | 0 | New York, NY |
Pfizer Ventures Co-Investors (236)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 15 | 0 | 00 |
|
|
| AbbVie Ventures | 0 | 0 |
|
|
|
| SR One | 0 | 00 |
|
|
|
| WuXi AppTec | 0 | 0 |
|
|
|
| HBM Healthcare Investments | 0 | 0 | 0 |
|
|